The Kitalys Institute is organizing Targeting Healthy Longevity (previously Targeting Metabesity) for 2023 different from previous years, where the conference was a once a year event taking place over several days in October.  For 2023, Targeting Healthy Longevity will consist of a series of free monthly conference session webinars, culminating in an in-person event near the end of the year.  

The inaugural session will be a fireside chat with FDA Commissioner Rob Califf, addressing for the first time, to our knowledge, the regulation of healthspan products, followed by a roundtable discussion among healthy longevity leaders on regulatory challenges and opportunities, on Wednesday, May 3, 2023, from 2 p.m. to 3:30 p.m. EDT.  Registration for this inaugural session can be found HERE.  

Additional free conference session webinars will be announced in the coming months, on topics from RCTs for supplements, to healthspan legislation and regulations to facilitate and incentivize the development of healthspan products, to emerging business models for Big Pharma/Big Food/Big Tech and their corresponding emerging companies, to metabolic approaches to neurodegenerative diseases, as well as information about the in-person event spotlighting progress in aging biomarkers and endpoints.      

​

Our audience cuts across sectors and disciplines for a multi-pronged approach to one of the most important health issues affecting people in all walks of life.

• Healthcare - Administrators, clinicians, and patient advocates interested in the prevention and delay of illness and aging

• Preclinical Research - Scientists involved in metabolic, cancer, dementia, cardiovascular and aging-related research

• Clinical Research - Investigators and healthcare providers involved in chronic non-communicable disease care and prevention

• Industry -  Corporate leaders and startups that are developing pharmaceutical, digital health, nutrition, new business models and other approaches to disease prevention and healthy aging

• Finance - Funders, payers and investors (including capital markets, philanthropies, government and insurers) in disease prevention and healthy aging

• Policy and Law - Government regulators, policy makers, elected officials, and advisors involved in Healthspan equity and the future of Healthspan

• Social Justice - Equity groups, social change agents, and philanthropic organizations interested in broadening access to healthy lifespan

• ​Strategy - Futurists, epidemiologists, social scientists, economists, bioethicists, and others thinking about how to harness emerging science behind Metabesity for global public health

• Academia - Instructors, administrators, students, and researchers across all fields of longevity, aging and Healthspan

• Communications - Journalists and marketing professionals who recognize hot topics and emerging trends

• The Interested Public